These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 3914914

  • 1. Inhibition of cyclophosphamide mutagenicity by beta-carotene.
    Belisario MA, Pecce R, Battista C, Panza N, Pacilio G.
    Biomed Pharmacother; 1985; 39(8):445-8. PubMed ID: 3914914
    [Abstract] [Full Text] [Related]

  • 2. Effect of beta-carotene on mutagenic activity of some antineoplastics.
    Belisario A, Panza N, Pacilio G.
    Acta Vitaminol Enzymol; 1985; 7 Suppl():75-8. PubMed ID: 3916048
    [Abstract] [Full Text] [Related]

  • 3. [In vivo studies on the transformation of cyclophosphamide to mutagenic metabolites].
    Della Morte R, Belisario MA, Farina C, Martire G, Staiano N, De Lorenzo F.
    Boll Soc Ital Biol Sper; 1982 Aug 30; 58(16):1061-7. PubMed ID: 7138675
    [Abstract] [Full Text] [Related]

  • 4. Modification of the mutagenicity and teratogenicity of cyclophosphamide in rats with inducers of the cytochromes P-450.
    Hales BF.
    Teratology; 1981 Aug 30; 24(1):1-11. PubMed ID: 7029774
    [Abstract] [Full Text] [Related]

  • 5. [Butylhydroxytoluene inhibition of the mutagenic activity of carcinogenic nitroso compounds and cyclophosphamide: the role of the glutathione conjugation reaction].
    Kalinina EV, Loknitskaia NN, Shuliakovskaia TS, Fonshteĭn LM.
    Vopr Onkol; 1987 Aug 30; 33(9):59-63. PubMed ID: 3310399
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the metabolizing capacity of S9 liver preparations from rats and mice using a test with Salmonella typhimurium TA100.
    Gajcy H, Pieńkowska K, Koziorowska J, Czarnomska A.
    Pol J Pharmacol Pharm; 1987 Aug 30; 39(1):27-32. PubMed ID: 3313326
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA.
    Toxic Rep Ser; 1999 Aug 30; (59):1-66, A1-E7. PubMed ID: 11803702
    [Abstract] [Full Text] [Related]

  • 11. Study on the mutagenicity and antimutagenicity of beta-ionone in the Salmonella/microsome assay.
    Gomes-Carneiro MR, Dias DM, Paumgartten FJ.
    Food Chem Toxicol; 2006 Apr 30; 44(4):522-7. PubMed ID: 16223554
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. NTP Technical Report on the metabolism, toxicity and predicted carcinogenicity of diazoaminobenzene (CAS No. 136-35-6).
    Ress NB, National Toxicology Program.
    Toxic Rep Ser; 2002 Sep 30; (73):1-23, A1-C6. PubMed ID: 12370695
    [Abstract] [Full Text] [Related]

  • 18. A study on the mutagenic effect of some Bulgarian drugs using the Salmonella/microsome test.
    Dimitrova K, Ivanov V, Bogoeva M, Golovinsky E, Markov K.
    Acta Physiol Pharmacol Bulg; 1983 Sep 30; 9(4):31-6. PubMed ID: 6375259
    [Abstract] [Full Text] [Related]

  • 19. Species-specific activation of phenacetin into bacterial mutagens by hamster liver enzymes and identification of N-hydroxyphenacetin O-glucuronide as a promutagen in the urine.
    Camus AM, Friesen M, Croisy A, Bartsch H.
    Cancer Res; 1982 Aug 30; 42(8):3201-8. PubMed ID: 7046920
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.